Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Selected Publications

Neuropharmacology Group

  1. Song S, Jiang L, Oyarzabal EA, Wilson B, Li Z, Shih YI, Wang Q, Hong JS. Loss of Brain Norepinephrine Elicits Neuroinflammation-Mediated Oxidative Injury and Selective Caudo-Rostral Neurodegeneration. Mol Neurobiol. 2018. [Abstract Song S, Jiang L, Oyarzabal EA, Wilson B, Li Z, Shih YI, Wang Q, Hong JS. Loss of Brain Norepinephrine Elicits Neuroinflammation-Mediated Oxidative Injury and Selective Caudo-Rostral Neurodegeneration. Mol Neurobiol. 2018.] 
  2. Chen SH, Sung YF, Oyarzabal EA, Tan YM, Leonard J, Guo MG, Li S, Wang QS, ChuCH, ChenSL, Lu RB, Hong JS. Physiological concentration of prostaglandin E2 exerts anti-inflammatory effects by inhibiting microglial production of superoxide through a novel pathway. Mol Neurobiology. 2018 (in press) [Abstract Chen SH, Sung YF, Oyarzabal EA, Tan YM, Leonard J, Guo MG, Li S, Wang QS, ChuCH, ChenSL, Lu RB, Hong JS. Physiological concentration of prostaglandin E2 exerts anti-inflammatory effects by inhibiting microglial production of superoxide through a novel pathway. Mol Neurobiology. 2018 (in press)] 
  3. Chen SH, Oyarzabal EA, Hong JS. Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration. Current opinion in pharmacology 2016 26():54-60. [Abstract Chen SH, Oyarzabal EA, Hong JS. Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration. Current opinion in pharmacology 2016 26():54-60.]
  4. Wang Q, Qian L, Chen SH, Chu CH, Wilson B, Oyarzabal E, Ali S, Robinson B, Rao D, Hong JS. Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models. Brain. 2015 May;138(Pt 5):1247-62. doi: 10.1093/brain/awv034. Epub 2015 Feb 25. [Abstract Wang Q, Qian L, Chen SH, Chu CH, Wilson B, Oyarzabal E, Ali S, Robinson B, Rao D, Hong JS. Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models. Brain. 2015 May;138(Pt 5):1247-62. doi: 10.1093/brain/awv034. Epub 2015 Feb 25.]
  5. Wang S, Chu CH, Stewart T, Ginghina C, Wang Y, Nie H, Guo M, Wilson B, Hong JS, Zhang J. α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation. Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):E1926-35. doi: 10.1073/pnas.1417883112. Epub 2015 Mar 30. [Abstract Wang S, Chu CH, Stewart T, Ginghina C, Wang Y, Nie H, Guo M, Wilson B, Hong JS, Zhang J. α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation. Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):E1926-35. doi: 10.1073/pnas.1417883112. Epub 2015 Mar 30.]
  6. Chen SH, Oyarzabal EA, Sung YF, Chu CH, Wang Q, Chen SL, Lu RB, Hong JS. Microglial regulation of immunological and neuroprotective functions of astroglia. Glia. 2015 Jan;63(1):118-31. doi: 10.1002/glia.22738. Epub 2014 Aug 13. [Abstract Chen SH, Oyarzabal EA, Sung YF, Chu CH, Wang Q, Chen SL, Lu RB, Hong JS. Microglial regulation of immunological and neuroprotective functions of astroglia. Glia. 2015 Jan;63(1):118-31. doi: 10.1002/glia.22738. Epub 2014 Aug 13.]
  7. Wang Q, Chu CH, Qian L, Chen SH, Wilson B, Oyarzabal E, Jiang L, Ali S, Robinson B, Kim HC, Hong JS. Substance P exacerbates dopaminergic neurodegeneration through neurokinin-1 receptor-independent activation of microglial NADPH oxidase. J Neurosci. 2014 Sep 10;34(37):12490-503. doi: 10.1523/JNEUROSCI.2238-14.2014. [Abstract Wang Q, Chu CH, Qian L, Chen SH, Wilson B, Oyarzabal E, Jiang L, Ali S, Robinson B, Kim HC, Hong JS. Substance P exacerbates dopaminergic neurodegeneration through neurokinin-1 receptor-independent activation of microglial NADPH oxidase. J Neurosci. 2014 Sep 10;34(37):12490-503. doi: 10.1523/JNEUROSCI.2238-14.2014.]
  8. Kumar A, Chen SH, Kadiiska MB, Hong JS, Zielonka J, Kalyanaraman B, Mason RP. Inducible nitric oxide synthase is key to peroxynitrite-mediated, LPS-induced protein radical formation in murine microglial BV2 cells. Free radical biology & medicine 2014 73():51-59. [Abstract Kumar A, Chen SH, Kadiiska MB, Hong JS, Zielonka J, Kalyanaraman B, Mason RP. Inducible nitric oxide synthase is key to peroxynitrite-mediated, LPS-induced protein radical formation in murine microglial BV2 cells. Free radical biology & medicine 2014 73():51-59.]
  9. Qin LY, Liu Y, Hong JS, Crews FT. NADPH oxidase and aging drive microglial activation, oxidative stress and dopaminergic neurodegeneration following systemic LPS administration. Glia, 2013 (in press).
  10. Zhou H, Liao JY, Aloor J, Nie H, Wilson BC, Fessler MB, Gao HM, Hong JS.  CD11b/CD18 (Mac-1) is a novel surface receptor for extracellular double-stranded RNA to mediate cellular inflammatory responses. J Immunology 190(1):115-125, 2013. [Abstract Zhou H, Liao JY, Aloor J, Nie H, Wilson BC, Fessler MB, Gao HM, Hong JS.  CD11b/CD18 (Mac-1) is a novel surface receptor for extracellular double-stranded RNA to mediate cellular inflammatory responses. J Immunology 190(1):115-125, 2013.]
  11. Gao HM, Zhou H, Hong JS. NADPH oxidases: novel therapeutic targets for neurodegenerative diseases. Trends Parmacol Sci. 33(6):295-303, 2012. [Abstract Gao HM, Zhou H, Hong JS. NADPH oxidases: novel therapeutic targets for neurodegenerative diseases. Trends Parmacol Sci. 33(6):295-303, 2012.]
  12. Hu X, Zhou H, Zhang D, Yang SF, Qian L, Wu HM, Chen P, Wilson B, Gao HM, Lu RB, Hong JS. Clozapine protects dopaminergic neurons from inflammation-induced damage by inhibiting microglial overactivation.  J Neuroimmune Pharmacol. 7(1):187-201, 2012. [Abstract Hu X, Zhou H, Zhang D, Yang SF, Qian L, Wu HM, Chen P, Wilson B, Gao HM, Lu RB, Hong JS. Clozapine protects dopaminergic neurons from inflammation-induced damage by inhibiting microglial overactivation.  J Neuroimmune Pharmacol. 7(1):187-201, 2012.]
  13. Chen SH, Wu HM, Ossola B, Schendzielorz N, Wilson BC, Chu CH, Chen SL, Wang Q, Zhang D, Qian L, Li X, Hong JS, Lu RB. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage. Br J Pharmacol. 165(2):494-505, 2012. [Abstract Chen SH, Wu HM, Ossola B, Schendzielorz N, Wilson BC, Chu CH, Chen SL, Wang Q, Zhang D, Qian L, Li X, Hong JS, Lu RB. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage. Br J Pharmacol. 165(2):494-505, 2012.]
  14. Zhou H, Zhang F, Chen SH, Zhang D, Wilson B, Hong JS,Gao HM. Rotenone activates phagocyte NADPH oxidase through binding to its membrane subunit gp91phox. Free Radic Biol Med. 52(2):303-313, 2012. [Abstract Zhou H, Zhang F, Chen SH, Zhang D, Wilson B, Hong JS,Gao HM. Rotenone activates phagocyte NADPH oxidase through binding to its membrane subunit gp91phox. Free Radic Biol Med. 52(2):303-313, 2012.]
  15. Qian L, Wu HM, Chen SH, Zhang D, Ali SF, Peterson L, Wilson B, Lu RB, Hong JS, Flood PM. Beta2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway. J Immunol. 186(7):4443-4454, 2011. [Abstract Qian L, Wu HM, Chen SH, Zhang D, Ali SF, Peterson L, Wilson B, Lu RB, Hong JS, Flood PM. Beta2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway. J Immunol. 186(7):4443-4454, 2011.]
  16. Gao HM, Zhang F, Zhou H, Kam W, Wilson B, Hong JS. Neuroinflammation and α-synuclein dysfunction potentiate each other driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. Environ Health Perspect. 119(6):807-814, 2011. [Abstract Gao HM, Zhang F, Zhou H, Kam W, Wilson B, Hong JS. Neuroinflammation and α-synuclein dysfunction potentiate each other driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. Environ Health Perspect. 119(6):807-814, 2011.]
  17. Gao HM, Hong JS. Gene-environment interactions: key to unraveling the mystery of Parkinson's disease. Prog Neurobiol. 94(1):1-19, 2011. [Abstract Gao HM, Hong JS. Gene-environment interactions: key to unraveling the mystery of Parkinson's disease. Prog Neurobiol. 94(1):1-19, 2011.]
  18. Gao, H.M., Zhou, H., Zhang, F., Wilson, B.C., Kam, W. and Hong, J.S. HMGB1 Acts on Microglia Mac1 to Mediate Chronic Neuroinflammation That Drives Progressive Neurodegeneration. The Journal of neuroscience. 31(3):1081-1092, 2011. [Abstract Gao, H.M., Zhou, H., Zhang, F., Wilson, B.C., Kam, W. and Hong, J.S. HMGB1 Acts on Microglia Mac1 to Mediate Chronic Neuroinflammation That Drives Progressive Neurodegeneration. The Journal of neuroscience. 31(3):1081-1092, 2011.]
  19. Levesque S, Wilson B, Gregoria V, Thorpe LB, Dallas S, Polikov VS, Hong JS, Block ML.  Reactive microgliosis: extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity. Brain 133(Pt 3):808-821, 2010. [Abstract Levesque S, Wilson B, Gregoria V, Thorpe LB, Dallas S, Polikov VS, Hong JS, Block ML.  Reactive microgliosis: extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity. Brain 133(Pt 3):808-821, 2010.]
  20. Zhang F, Qian L, Flood PM, Jin Shi JS, Hong JS, Gao HM. Inhibition of IkappaB kinase-beta protects dopamine neurons against lipopolysaccharide-induced neurotoxicity. J Pharmcol Exp Ther. 333(3):822-833, 2010.   [Abstract Zhang F, Qian L, Flood PM, Jin Shi JS, Hong JS, Gao HM. Inhibition of IkappaB kinase-beta protects dopamine neurons against lipopolysaccharide-induced neurotoxicity. J Pharmcol Exp Ther. 333(3):822-833, 2010.  ]
  21. Zhang F, Shi JS, Zhou H, Hong JS, Gao HM. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions. Mol Pharmacol. 78(3):466-477, 2010. [Abstract Zhang F, Shi JS, Zhou H, Hong JS, Gao HM. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions. Mol Pharmacol. 78(3):466-477, 2010.]
  22. Luo L, Rodriguez E, Jerbi K, Lachaux JP, Martinerie J, Corbetta M, Shulman GL, Piomelli D, Turrigiano GG, Nelson SB, Joels M, de Kloet ER, Holsboer F, Amodio DM, Frith CD, Block ML, Zecca L, Hong JS, Dantzer R, Kelley KW, Craig AD. Ten years of Nature Reviews Neuroscience: insights from the highly cited. Nat Rev Neurosci. 11(10):718-726, 2010.   [Abstract Luo L, Rodriguez E, Jerbi K, Lachaux JP, Martinerie J, Corbetta M, Shulman GL, Piomelli D, Turrigiano GG, Nelson SB, Joels M, de Kloet ER, Holsboer F, Amodio DM, Frith CD, Block ML, Zecca L, Hong JS, Dantzer R, Kelley KW, Craig AD. Ten years of Nature Reviews Neuroscience: insights from the highly cited. Nat Rev Neurosci. 11(10):718-726, 2010.  ]
  23. Qian L, Flood PM, Hong JS.  Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J Neural Transm. 117(8):971-979, 2010. [Abstract Qian L, Flood PM, Hong JS.  Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J Neural Transm. 117(8):971-979, 2010.]
  24. Wu HM, Tzeng NS, Qian L, Wei SJ, Hu X, Chen SH, Rawls SM, Flood P, Hong JS, Lu RB. Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation.  Neuropsychopharmacology 34(10): 2344-2357, 2009. [Abstract Wu HM, Tzeng NS, Qian L, Wei SJ, Hu X, Chen SH, Rawls SM, Flood P, Hong JS, Lu RB. Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation.  Neuropsychopharmacology 34(10): 2344-2357, 2009.]
  25. Zhang D, Hu X, Qian L, Wilson B, Lee C, Flood P, Langenbach R, Hong JS. Prostaglandin E2 released from activated microglia enhances astrocyte proliferation in vitro. Toxicol Appl Pharmacol. 238(1):64-70, 2009. [Abstract Zhang D, Hu X, Qian L, Wilson B, Lee C, Flood P, Langenbach R, Hong JS. Prostaglandin E2 released from activated microglia enhances astrocyte proliferation in vitro. Toxicol Appl Pharmacol. 238(1):64-70, 2009.]
  26. Qian, L., Wei, S-J, Zhang, D., Hu, X., Xu, Z., Wilson, B., El-Benna, J., Hong, J.S. and Flood, P.M. Potent anti-inflammatory and neuroprotective effects of TGFb1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. J Immunol. 181(1):660-668, 2008. [Abstract Qian, L., Wei, S-J, Zhang, D., Hu, X., Xu, Z., Wilson, B., El-Benna, J., Hong, J.S. and Flood, P.M. Potent anti-inflammatory and neuroprotective effects of TGFb1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. J Immunol. 181(1):660-668, 2008.]
  27. Block, M. Zecca, L. O’Callahan, J. and Hong, J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanism. Nature Rev Neurosci. 8(1):57-69, 2007.  [Abstract Block, M. Zecca, L. O’Callahan, J. and Hong, J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanism. Nature Rev Neurosci. 8(1):57-69, 2007. ]
  28. Zhang W, Wang T, Liu J, Wilson B, Meng Y, Ali S, Kim H, Zhang W, Hong JS. 3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited dopaminergic neurodegeneration both in vivo and in vitro. FASEB J. 20(14):2496-2511, 2006. [Abstract Zhang W, Wang T, Liu J, Wilson B, Meng Y, Ali S, Kim H, Zhang W, Hong JS. 3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited dopaminergic neurodegeneration both in vivo and in vitro. FASEB J. 20(14):2496-2511, 2006.]
  29. Chen, P., Peng, G, Li, G., Yang, S., Wu, X., Wang, C., Wilson, B., Lu, R., Gean, P., Chuang, D. and Hong, J.S. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry 11(12): 1116-1125, 2006.  [Abstract Chen, P., Peng, G, Li, G., Yang, S., Wu, X., Wang, C., Wilson, B., Lu, R., Gean, P., Chuang, D. and Hong, J.S. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry 11(12): 1116-1125, 2006. ]
  30. Zhang, W, Wang, T, Pei, Z, Meng, Y., Wu, X, Wilson, B, Zhang, W, Hong, JS and Zhang, J. Aggregated a-synuclein activates microglia: a process leading to disease progression in Parkinson’s disease. FASEB J. 19(6): 533-542, 2005.  [Abstract Zhang, W, Wang, T, Pei, Z, Meng, Y., Wu, X, Wilson, B, Zhang, W, Hong, JS and Zhang, J. Aggregated a-synuclein activates microglia: a process leading to disease progression in Parkinson’s disease. FASEB J. 19(6): 533-542, 2005. ]
  31. Qin, L., Block, M., Liu, Y., Bienstock, R., Pei, Z., Zhang, W., Wu, X., Wilson, B., Burka, T. and Hong, J.S.: Microglial NADPH oxidase is a novel target for femtomolar neuroprotection against oxidative stress. FASEB J. 19: 550-557, 2005.  [Abstract Qin, L., Block, M., Liu, Y., Bienstock, R., Pei, Z., Zhang, W., Wu, X., Wilson, B., Burka, T. and Hong, J.S.: Microglial NADPH oxidase is a novel target for femtomolar neuroprotection against oxidative stress. FASEB J. 19: 550-557, 2005. ]
  32. Zhang, W, Qin, L, Wang T, Wei S. Gao H. Liu J, Wilson B, Liu B, Zhang W, Kim H, and Hong JS. 3-Hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity. FASEB J. 19(3): 395-397, 2005.  [Abstract Zhang, W, Qin, L, Wang T, Wei S. Gao H. Liu J, Wilson B, Liu B, Zhang W, Kim H, and Hong JS. 3-Hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity. FASEB J. 19(3): 395-397, 2005. ]
  33. Qin L, Liu Y, Wang T, Wei S, Block M, Wilson B, Liu B. and Hong JS. NADPH oxidase mediates LPS-induced neurotoxicity and pro-inflammatory gene expression in activated microglia. J Biol Chem. 279(2):1415-1421, 2004.  [Abstract Qin L, Liu Y, Wang T, Wei S, Block M, Wilson B, Liu B. and Hong JS. NADPH oxidase mediates LPS-induced neurotoxicity and pro-inflammatory gene expression in activated microglia. J Biol Chem. 279(2):1415-1421, 2004. ]
  34. Liu B. and Hong JS. Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ Health Perspect. 111(8): 1065-1073, 2003.  [Abstract Liu B. and Hong JS. Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ Health Perspect. 111(8): 1065-1073, 2003. ]
  35. Gao H, Liu B, Zhang W, and Hong JS. Novel anti-inflammatory therapy for Parkinson’s disease. Trends Pharmacol Sci. 24(8):395-401, 2003. [Abstract Gao H, Liu B, Zhang W, and Hong JS. Novel anti-inflammatory therapy for Parkinson’s disease. Trends Pharmacol Sci. 24(8):395-401, 2003.]
  36. Gao H, Liu B, and Hong JS. Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. J Neurosci. 23(15): 6181-6187, 2003.  [Abstract Gao H, Liu B, and Hong JS. Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. J Neurosci. 23(15): 6181-6187, 2003. ]
  37. Gao H, Hong JS, Zhang W, Liu B. Synergistic dopaminergic neurotoxicity of pesticide rotenone and inflammagen LPS: relevance to the etiology of Parkinson’s disease. J Neurosci. 23:1228-1236, 2003. [Abstract Gao H, Hong JS, Zhang W, Liu B. Synergistic dopaminergic neurotoxicity of pesticide rotenone and inflammagen LPS: relevance to the etiology of Parkinson’s disease. J Neurosci. 23:1228-1236, 2003.]
  38. Liu B. and Hong JS. Role of microglial activation in inflammation-mediated neurodegenerative diseases: study of mechanism and strategies for therapeutic intervention. J Pharma Exp Ther. 304(1): 1-7, 2003.  [Abstract Liu B. and Hong JS. Role of microglial activation in inflammation-mediated neurodegenerative diseases: study of mechanism and strategies for therapeutic intervention. J Pharma Exp Ther. 304(1): 1-7, 2003. ]
  39. Gao H, Jiang J, Wilson B, Zhang W, Hong JS, Liu B. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem. 81(6): 1285-1297, 2002.  [Abstract Gao H, Jiang J, Wilson B, Zhang W, Hong JS, Liu B. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem. 81(6): 1285-1297, 2002. ]
  40. Gao H, Hong JS, Zhang W, Liu B. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci. 22(3): 782-790, 2002.  [Abstract Gao H, Hong JS, Zhang W, Liu B. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci. 22(3): 782-790, 2002. ]
  41. Liu B, Qin L, Yang S, Wilson B, Liu Y, Hong, JS. Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage. J Pharm Exp Ther. 298(3): 1133-1141, 2001.  [Abstract Liu B, Qin L, Yang S, Wilson B, Liu Y, Hong, JS. Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage. J Pharm Exp Ther. 298(3): 1133-1141, 2001. ]
  42. Kim WG, Wilson BC, Jeohn GH, Hong JS. Differential susceptibility of neurons in different brain regions in lipopolysaccharide (LPS)-induced neurotoxicity. J Neurosci. 20(16): 6309-6316, 2000.  [Abstract Kim WG, Wilson BC, Jeohn GH, Hong JS. Differential susceptibility of neurons in different brain regions in lipopolysaccharide (LPS)-induced neurotoxicity. J Neurosci. 20(16): 6309-6316, 2000. ]
Back
to Top